PRODROMAL SCHIZOPHRENIA
Clinical trials for PRODROMAL SCHIZOPHRENIA explained in plain language.
Never miss a new study
Get alerted when new PRODROMAL SCHIZOPHRENIA trials appear
Sign up with your email to follow new studies for PRODROMAL SCHIZOPHRENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stopping schizophrenia before it starts?
Disease control Recruiting nowThis study is testing whether a drug that boosts a specific brain chemical (NMDA) can help control symptoms in people showing early warning signs of schizophrenia. It will involve 48 participants who are still experiencing symptoms after a 6-week health program. The main goal is …
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: PHASE2 • Sponsor: China Medical University Hospital • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
Could a common supplement help prevent schizophrenia?
Symptom relief Recruiting nowThis study tests whether N-acetylcysteine (NAC), a safe antioxidant supplement, can reduce early psychosis-like symptoms in 90 people at high risk for schizophrenia. Participants take NAC or a placebo for 8 weeks, and researchers measure changes in symptoms and brain activity. Th…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC
-
Brain training may shield teens from psychosis
Knowledge-focused Recruiting nowThis study tests a 10-week, at-home program called SCORES that uses computer exercises and group support to boost processing speed—how quickly the brain handles information—in 54 teens at high risk for psychosis. The goal is to see if faster thinking leads to better social skills…
Matched conditions: PRODROMAL SCHIZOPHRENIA
Phase: NA • Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC